These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

685 related articles for article (PubMed ID: 8020885)

  • 21. Interobserver Variability in Scoring Liver Biopsies with a Diagnosis of Alcoholic Hepatitis.
    Horvath B; Allende D; Xie H; Guirguis J; Jeung J; Lapinski J; Patil D; McCullough AJ; Dasarathy S; Liu X
    Alcohol Clin Exp Res; 2017 Sep; 41(9):1568-1573. PubMed ID: 28654190
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Assessment of histological features and outcome of interferon therapy in chronic hepatitis C.
    Kumagai N; Kuramochi S; Toda K; Iwabuchi N; Tsuchimoto K; Tsunematsu S; Saito H; Morizane T; Tsuchiya M; Ishii H
    J Gastroenterol; 1996 Feb; 31(1):69-74. PubMed ID: 8808431
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Histological features predictive of liver fibrosis in chronic hepatitis C infection.
    Paradis V; Mathurin P; Laurent A; Charlotte F; Vidaud M; Poynard T; Hoang C; Opolon P; Bedossa P
    J Clin Pathol; 1996 Dec; 49(12):998-1004. PubMed ID: 9038738
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A histopathological study of the effects of 6-month versus 12-month interferon alpha-2b therapy in chronic hepatitis C.
    Ziol M; Nhieu JT; Roudot-Thoraval F; Métreau JM; Deugnier Y; Dhumeaux D; Zafrani ES
    J Hepatol; 1996 Dec; 25(6):833-41. PubMed ID: 9007710
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Importance of specimen size in accurate needle liver biopsy evaluation of patients with chronic hepatitis C.
    Schiano TD; Azeem S; Bodian CA; Bodenheimer HC; Merati S; Thung SN; Hytiroglou P
    Clin Gastroenterol Hepatol; 2005 Sep; 3(9):930-5. PubMed ID: 16234033
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Correlation between histological features of liver biopsy specimens and clinical effect of interferon on patients with chronic hepatitis C].
    Kumagai N; Kuramochi S
    Nihon Rinsho; 1994 Jul; 52(7):1769-73. PubMed ID: 7521416
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Pathological features of liver biopsy from 66 cases of long term blood donors with chronic hepatitis C].
    Ren J; Wang L; Wang T; Lu J; Lei C; Liu X
    Zhonghua Bing Li Xue Za Zhi; 2000 Dec; 29(6):428-31. PubMed ID: 11866945
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection.
    Regev A; Berho M; Jeffers LJ; Milikowski C; Molina EG; Pyrsopoulos NT; Feng ZZ; Reddy KR; Schiff ER
    Am J Gastroenterol; 2002 Oct; 97(10):2614-8. PubMed ID: 12385448
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High-Throughput, Machine Learning-Based Quantification of Steatosis, Inflammation, Ballooning, and Fibrosis in Biopsies From Patients With Nonalcoholic Fatty Liver Disease.
    Forlano R; Mullish BH; Giannakeas N; Maurice JB; Angkathunyakul N; Lloyd J; Tzallas AT; Tsipouras M; Yee M; Thursz MR; Goldin RD; Manousou P
    Clin Gastroenterol Hepatol; 2020 Aug; 18(9):2081-2090.e9. PubMed ID: 31887451
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interobserver agreement in hepatitis C grading and staging and in the Banff grading schema for acute cellular rejection: the "hepatitis C 3" multi-institutional trial experience.
    Netto GJ; Watkins DL; Williams JW; Colby TV; dePetris G; Sharkey FE; Corless CL; Lewin D; Petrovic L; Sharma S; Kanel G; Theise N; West AB; Koehler A; Jhala NC; Lefkowitch J; Lezzoni J; Jennings LW; Tillery GW; Klintmalm GB;
    Arch Pathol Lab Med; 2006 Aug; 130(8):1157-62. PubMed ID: 16886238
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Liver biopsy in the real world-reporting, expert concordance and correlation with a pragmatic clinical diagnosis.
    Kim HP; Idowu MO; Mospan AR; Allmon AG; Roden M; Newsome P; Lok AS; Thuluvath PJ; Taunk J; Fried MW; Sanyal AJ; Barritt AS;
    Aliment Pharmacol Ther; 2021 Dec; 54(11-12):1472-1480. PubMed ID: 34694013
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Application of a new histological staging and grading system for primary biliary cirrhosis to liver biopsy specimens: Interobserver agreement.
    Nakanuma Y; Zen Y; Harada K; Sasaki M; Nonomura A; Uehara T; Sano K; Kondo F; Fukusato T; Tsuneyama K; Ito M; Wakasa K; Nomoto M; Minato H; Haga H; Kage M; Yano H; Haratake J; Aishima S; Masuda T; Aoyama H; Miyakawa-Hayashino A; Matsumoto T; Sanefuji H; Ojima H; Chen TC; Yu E; Kim JH; Park YN; Tsui W
    Pathol Int; 2010 Mar; 60(3):167-74. PubMed ID: 20403042
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Feasibility of histological grading and staging of chronic viral hepatitis using specimens obtained by thin-needle biopsy.
    Petz D; Klauck S; Röhl FW; Malfertheiner P; Roessner A; Röcken C
    Virchows Arch; 2003 Mar; 442(3):238-44. PubMed ID: 12647213
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Time course of histological changes in patients with a sustained biochemical and virological response to interferon-alpha therapy for chronic hepatitis C virus infection.
    Tsubota A; Kumada H; Chayama K; Arase Y; Saitoh S; Koida I; Suzuki Y; Kobayashi M; Murashima N; Ikeda K
    J Hepatol; 1997 Jul; 27(1):49-55. PubMed ID: 9252073
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reliability of histopathologic assessment for the differentiation of recurrent hepatitis C from acute rejection after liver transplantation.
    Regev A; Molina E; Moura R; Bejarano PA; Khaled A; Ruiz P; Arheart K; Berho M; Drachenberg CB; Mendez P; O'Brien C; Jeffers L; Tzakis A; Schiff ER
    Liver Transpl; 2004 Oct; 10(10):1233-9. PubMed ID: 15376303
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Histological evolution of chronic hepatitis C. Factors related to progression.
    Vaquer P; Canet R; Llompart A; Riera J; Obrador A; Gayá J
    Liver; 1994 Oct; 14(5):265-9. PubMed ID: 7527889
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Histopathological study of chronic hepatitis B and C: a comparison of two scoring systems.
    Rozario R; Ramakrishna B
    J Hepatol; 2003 Feb; 38(2):223-9. PubMed ID: 12547412
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serum aminotransferase levels and histological disease in chronic hepatitis C.
    Michielsen PP; Hauben EI; Ramon AM; Van Marck EA; Pelckmans PA
    Acta Gastroenterol Belg; 1997; 60(1):11-4. PubMed ID: 9144972
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Histological improvement of chronic hepatitis B, and non-A, non-B with interferon treatment: application of a numerical scoring system for evaluating sequential morphologic changes.
    Okuno T; Shindo M; Arai K; Matsumoto M; Takeda M
    Gastroenterol Jpn; 1990 Feb; 25(1):70-7. PubMed ID: 2106467
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [An evaluation of the degree of the morphological activity and the stage of the process in patients with chronic liver diseases caused by coinfection with the hepatitis B, C and/or D viruses].
    Siutkin VE; Lopatkina TN; Popova IV
    Arkh Patol; 1998; 60(6):37-41. PubMed ID: 9949904
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 35.